Background: Pulmonary hypertension (PH) is a severe progressive disease, associated with reduced exercise capacity and poor quality of life. Although scientific evidence supports the incorporation of specialized training in the treatment of PH, it is only available in a few countries. Objectives and Methods: This article aims to share the experience of implementing a PH rehabilitation program, to summarize the barriers and prerequisites for launching this service, and to assess its early effect. We retrospectively analyzed our pathway in organizing this program, by singling out essential steps. Results: The preparation phase took about 14 months. Establishing and running of a PH rehabilitation program required dedicated rehabilitation specialists to join the multidisciplinary PH expert team. Team members needed to gain special knowledge on exercise training in severely compromised patients; thus, supervision and education by experienced consultants was crucial. The main eligibility criteria for patients were stable status, optimal medical treatment, and motivation to undergo the training. The first results evaluating the effect of a specialized PH training program in 9 patients are promising. Seven of them improved their functional capacity over the period of 15 weeks. Conclusions: Despite a number of challenges and barriers, the implementation of a specialized rehabilitation program should be encouraged in a few dedicated PH expert centers per country, who are capable to fulfill all prerequisites and organizational aspects. Local PH experts, supervision by an experienced center, in-patient rehabilitation facilities, dedicated personnel, equipment, and patient motivation are essential.

1.
Galiè
N
,
Humbert
M
,
Vachiery
J-L
,
Gibbs
S
,
Lang
I
,
Torbicki
A
,
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
.
Eur Heart J
.
2016 Jan 1
;
37
(
1
):
67
119
.
2.
Simonneau
G
,
Montani
D
,
Celermajer
DS
,
Denton
CP
,
Gatzoulis
MA
,
Krowka
M
,
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
.
Eur Respir J
.
2019
;
53
(
1
):
1801913
. .
3.
Mereles
D
,
Ehlken
N
,
Kreuscher
S
,
Ghofrani
S
,
Hoeper
MM
,
Halank
M
,
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension
.
Circulation
.
2006 Oct 3
;
114
(
14
):
1482
9
. .
4.
Fox
BD
,
Kassirer
M
,
Weiss
I
,
Raviv
Y
,
Peled
N
,
Shitrit
D
,
Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension
.
J Card Fail
.
2011 Mar
;
17
(
3
):
196
200
. .
5.
Chan
L
,
Chin
LMK
,
Kennedy
M
,
Woolstenhulme
JG
,
Nathan
SD
,
Weinstein
AA
,
Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension
.
Chest
.
2013 Feb 1
;
143
(
2
):
333
43
. .
6.
Weinstein
AA
,
Chin
LMK
,
Keyser
RE
,
Kennedy
M
,
Nathan
SD
,
Woolstenhulme
JG
,
Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension
.
Respir Med
.
2013 May
;
107
(
5
):
778
84
. .
7.
Grünig
E
,
Ehlken
N
,
Ghofrani
A
,
Staehler
G
,
Meyer
FJ
,
Juenger
J
,
Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension
.
Respiration
.
2011
;
81
(
5
):
394
401
. .
8.
Pandey
A
,
Garg
S
,
Khunger
M
,
Garg
S
,
Kumbhani
DJ
,
Chin
KM
,
Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-Analysis
.
Circ Heart Fail
.
2015 Nov
;
8
(
6
):
1032
43
. .
9.
Yuan
P
,
Yuan
X-T
,
Sun
X-Y
,
Pudasaini
B
,
Liu
J-M
,
Hu
Q-H
.
Exercise training for pulmonary hypertension: a systematic review and meta-analysis
.
Int J Cardiol
.
2015 Jan 15
;
178
:
142
6
. .
10.
Nagel
C
,
Prange
F
,
Guth
S
,
Herb
J
,
Ehlken
N
,
Fischer
C
,
Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension
.
PLoS One
.
2012
;
7
(
7
):
e41603
. .
11.
Ehlken
N
,
Lichtblau
M
,
Klose
H
,
Weidenhammer
J
,
Fischer
C
,
Nechwatal
R
,
Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial
.
Eur Heart J
.
2016 Jan 1
;
37
(
1
):
35
44
. .
12.
Buys
R
,
Avila
A
,
Cornelissen
VA
.
Exercise training improves physical fitness in patients with pulmonary arterial hypertension: a systematic review and meta-analysis of controlled trials
.
BMC Pulm Med
.
2015 Apr 22
;
15
:
40
. .
13.
Grünig
E
,
Maier
F
,
Ehlken
N
,
Fischer
C
,
Lichtblau
M
,
Blank
N
,
Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
.
Arthritis Res Ther
.
2012 Jun 18
;
14
(
3
):
R148
. .
14.
Grünig
E
,
Lichtblau
M
,
Ehlken
N
,
Ghofrani
HA
,
Reichenberger
F
,
Staehler
G
,
Safety and efficacy of exercise training in various forms of pulmonary hypertension
.
Eur Respir J
.
2012 Jul
;
40
(
1
):
84
92
. .
15.
Grünig
E
,
Eichstaedt
C
,
Barberà
J-A
,
Benjamin
N
,
Blanco
I
,
Bossone
E
,
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension
.
Eur Respir J
.
2019
;
53
(
2
):
1800332
. .
16.
MacKenzie
A
,
Johnson
M
.
Demand for exercise training in patients with pulmonary arterial hypertension in Scotland
.
Eur Respir J
.
2015 Nov
;
46
(
5
):
1513
5
. .
17.
Grünig
E
,
MacKenzie
A
,
Peacock
AJ
,
Eichstaedt
CA
,
Benjamin
N
,
Nechwatal
R
,
Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial
.
Eur Heart J
. Forthcoming.
2020 Nov 24
. .
18.
McHorney
CA
,
Ware
JE
,
Raczek
AE
.
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
.
Med Care
.
1993 Mar
;
31
(
3
):
247
63
. .
19.
Kubilius
R
,
Jasiukevičienė
L
,
Grižas
V
,
Kubilienė
L
,
Jakubsevičienė
E
,
Vasiliauskas
D
.
The impact of complex cardiac rehabilitation on manifestation of risk factors in patients with coronary heart disease
.
Medicina (Kaunas)
.
2012
;
48
(
3
):
166
73
.
20.
Grazuleviciene
R
,
Vencloviene
J
,
Kubilius
R
,
Grizas
V
,
Dedele
A
,
Grazulevicius
T
,
The effect of park and urban environments on coronary artery disease patients: a randomized trial
.
BioMed Res Int
.
2015
;
2015
:
403012
. .
21.
Slivovskaja
I
,
Buzinskaitė
J
,
Ryliškytė
L
,
Balsytė
J
,
Navickas
R
,
Puronaitė
R
,
Positive impact of a 4-week duration supervised aerobic training on anthropometric, metabolic, hemodynamic and arterial wall parameters in metabolic syndrome subjects
.
Semin Cardiovasc Med
.
2017 Jun
;
23
(
1
):
11
6
. .1
22.
Benzo
R
,
Wetzstein
M
,
Neuenfeldt
P
,
McEvoy
C
.
Implementation of physical activity programs after COPD hospitalizations: lessons from a randomized study
.
Chron Respir Dis
.
2015 Feb
;
12
(
1
):
5
10
. .
23.
Lan
C-C
,
Chu
W-H
,
Yang
M-C
,
Lee
C-H
,
Wu
Y-K
,
Wu
C-P
.
Benefits of pulmonary rehabilitation in patients with COPD and normal exercise capacity
.
Respir Care
.
2013 Sep
;
58
(
9
):
1482
8
. .
24.
Oral
A
,
Juocevicius
A
,
Lukmann
A
,
Takáč
P
,
Tederko
P
,
Hāznere
I
,
Evidence-based position paper on Physical and Rehabilitation Medicine (PRM) professional practice for people with respiratory conditions. The European PRM position (UEMS PRM Section)
.
Eur J Phys Rehabil Med
.
2018 Aug
;
54
(
4
):
624
33
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.